JNCE Shares Outstanding History



Below is a table of the JNCE shares outstanding history going back to 1/27/2017:

Date JNCE Shares Outstanding
1/27/201730.16M
3/1/201732.16M
4/28/201732.17M
8/4/201732.19M
11/10/201732.25M
2/28/201832.39M
5/4/201832.48M
8/3/201832.63M
11/9/201832.70M
3/1/201932.97M
5/3/201932.97M
8/2/201932.98M
8/5/201927.05M
11/1/201933.23M
2/21/202034.05M
5/1/202034.05M
7/31/202034.07M
11/2/202039.85M
2/19/202145.39M
4/30/202151.21M
7/30/202151.23M
11/1/202151.24M
2/28/202251.66M
5/2/202251.67M
7/29/202251.69M
11/7/202251.69M
3/7/202352.14M

Also see: JNCE Market Cap History
JNCE YTD Return
JNCE Historical Shares Outstanding:
+9.37% CAGR
JNCE Historical Shares Outstanding: +9.37% CAGR

Mouse over chart for data details
1/27/2017 ...3/7/2023
Jounce Therapeutics is a clinical-stage immunotherapy company focuses on the treatment of cancer by developing therapies that enable the immune system to attack tumors. Co.'s product candidates include: JTX-8064, an antibody that binds to Leukocyte Immunoglobulin Like Receptor B2; Vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells commonly found in several solid tumors; Pimivalimab, a clinical-stage anti-PD-1 antibody for potential use in combination with its product candidates; and GS-1811, a monoclonal antibody that depletes T regulatory cells in the tumor microenvironment. We show 27 historical shares outstanding datapoints in our coverage of JNCE's shares outstanding history.

Understanding the changing numbers of JNCE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like JNCE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching JNCE by allowing them to research JNCE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree JNCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Jounce Therapeutics (JNCE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

JNJ Shares Outstanding History
JNP Shares Outstanding History
JUPW Shares Outstanding History
KA Shares Outstanding History
KA Shares Outstanding History
KALA Shares Outstanding History
KALV Shares Outstanding History
KDMN Shares Outstanding History
KDNY Shares Outstanding History
KEQU Shares Outstanding History
More Healthcare companies »

 

JNCE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.